Filing Details
- Accession Number:
- 0001209191-23-014638
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-03-02 16:16:42
- Reporting Period:
- 2023-02-28
- Accepted Time:
- 2023-03-02 16:16:42
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1685316 | Obseva Sa | OBSV | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1731550 | Ernest Loumaye | C/O Obseva Sa C/O Chemin Des Aulx, 12, Plan-Les-Ouates Geneva V8 1228 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Shares | Acquisiton | 2023-02-28 | 4,000,000 | $0.11 | 6,000,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Converted from Swiss franc purchase price of CHF 0.104 using an exchange rate of CHF 1.06 per U.S. dollar.
Billionaire Hedge Funds
